Study shows cholesterol-lowering statins are underused
Patients with high cholesterol are prescribed statins, but a recent study said about half of these patients will stop using the medication within the first year. Read More »
Cigna enters alliance to improve health care, reduce costs in Central Florida
Cigna and Central Florida Affordable Care LLC announced on Thursday a collaboration to lower costs while improving health care and patient experience under Cigna’s accountable care organizations program called Cigna Collaborative Care. Read More »
Severe acne treatment is delayed by ineffective antibiotics
A study of records at New York University's Langone Medical Center determined that too many patients being treated for severe acne are being left on ineffective antibiotics for too long before being prescribed isotretinoin (also known by its former brand name Accutane). Read More »
FDA to delay enforcement of Track and Trace requirements
Track and Trace requirements scheduled to go into effect Sunday have been delayed until March 1, according to a Thursday announcement from the Food and Drug Administration (FDA). Read More »
Arena Pharmaceuticals initiates Phase 1b trial of APD371
Arena Pharmaceuticals Inc. has begun patient dosing in a Phase 1b multiple-ascending dose clinical trial of APD371, a selective agonist of the cannabinoid 2 (CB2) receptor. Read More »
FDA approves first-of-its-kind melanoma treatment
Imlygic (talimogene laherparepvec) has become the first FDA-approved oncolytic virus therapy indicated for the treatment of melanoma lesions in the skin and lymph nodes. Read More »
FDA approves Merrimack's Onivyde as pancreatic cancer treatment
PharmaEngine Inc. recently announced the U.S. Food and Drug Administration's (FDA) approval of Merimack's Onivyde (irinotecan liposome injection) in combination with fluorouracil (5-FU) and leucovorin (LV). Read More »
ASHP updates best practices resource
The American Society of Health-System Pharmacists (ASHP) recently published its annual compilation, ASHP Best Practices, featuring information such as quality policy positions, statements, guidelines, therapeutic position statements, and therapeutic and clinical practice guidelines for the pharmacy profession. Read More »
ClearPath Development launches second vaccine company
ClearPath Development Co. has partnered with Astellas Pharma Inc. to form a second vaccine company, Nosocomial Vaccine Corp. (NVC). Read More »
CVS opens 1,000th MinuteClinic facility
CVS Health's walk-in medical clinic, MinuteClinic, reached a milestone recently with the opening of its 1,000th location on Dupont Circle in Washington, D.C. Read More »
Lawmakers seek corrections to Medicare Plan Finder website
To help Medicare beneficiaries make better choices as they choose drug plans, pending regulatory guidance could increase transparency and accuracy of information on the Medicare Plan Finder website. Read More »
UBIC, M3 partnering to develop AI technology for health care
International litigation support provider UBIC Inc. has entered into a partnership with M3 Inc. to develop services through artificial intelligence (AI) technology to be used in the health care and pharmaceuticals industries. Read More »
FDA approves Yervoy for late-stage melanoma
The Food and Drug Administration (FDA) has expanded the approved uses of Yervoy (ipilimumab) to treat patients with Stage III melanoma. Read More »
Cancer drug Onivyde receives FDA approval
The Food and Drug Administration (FDA) has approved Onivyde (irinotecan liposome injection), in combination with fluorouracil and leucovorin, for patients with advanced pancreatic cancer who have been treated previously with gemcitabine-based chemotherapy. Read More »
Walgreens to acquire Rite Aid
Walgreens Boots Alliance, Inc. and Rite Aid Corp. said Tuesday they have entered into a definitive agreement under which Walgreens will acquire all outstanding shares of Rite Aid.Under the agreement, Walgreens will acquire Rite Aid shares for $9 per share, for a total enterprise value of approximately $17.2 billion. Read More »
Walgreens: Customers and patients will benefit from Rite Aid acquisition
Walgreens announces purchase of Rite Aid in $17.2 billion deal. Read More »
Report looks at drug wholesalers and American health care
A recent study by the Drug Channels Institute, a leading management educator for and about the pharmaceutical industry, analyzed the highly dynamic prescription drug distribution industry. Read More »
Elliot Physician Network collaborating with Cigna to expand care initiative
Cigna said Monday it recently launched a collaborative care initiative, Cigna Collaborative Care, with the Elliot Physician Network to improve patient access to health care, increase care coordination and achieve improved health, affordability and patient experience in Southern New Hampshire. Read More »
Study shows pharmacists can improve patient health through networking
A study conducted by the National Community Pharmacists Association (NCPA) found that independent community pharmacists are able to improve patient health by networking together across diverse practice settings, an article in Pharmacy Times said on Monday. Read More »
Obama offers plan to fight drug abuse
President Barack Obama announced a plan Wednesday to combat the nation's drug crisis by boosting training for care providers who prescribe opioids and improving access to treatment facilities for people with addiction. “The drug epidemic this country is facing can only be defeated through collaboration and support from government officials as well as care providers and technology leaders,” Surescripts CEO Tom Skelton said. Read More »
Alerts Sign-up